INS and type 1 diabetes mellitus: In the progression of both type 1 diabetes mellitus (T1DM) and type 2 DM (T2DM), there comes a point where a threshold percentage of β-cells become dysfunctional, leading to a reliance on exogenous insulin administration for the treatment of patients with DM.